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2 
Abstract 21 
Lipid content and composition in aquafeeds have changed rapidly as a result of the recent drive to 22 
replace ecologically limited marine ingredients, fishmeal and fish oil (FO). Terrestrial plant products 23 
are the most economic and sustainable alternative; however, plant meals and oils are devoid of 24 
physiologically important cholesterol and long-chain polyunsaturated fatty acids (LC-PUFA), 25 
eicosapentaenoic (EPA), docosahexaenoic (DHA) and arachidonic (ARA) acids. Although 26 
replacement of dietary FO with vegetable oil (VO) has little effect on growth in Atlantic salmon 27 
(Salmo salar), several studies have shown major effects on the activity and expression of genes 28 
involved in lipid metabolism. In vertebrates, sterols and LC-PUFA play crucial roles in lipid 29 
metabolism by direct interaction with lipid-sensing transcription factors (TF) and consequent 30 
regulation of target genes. The primary aim of the present study was to elucidate the role of key TFs 31 
in the transcriptional regulation of lipid metabolism in fish by transfection and overexpression of TFs. 32 
The results show that the expression of genes of LC-PUFA biosynthesis (elovl and fads2) and 33 
cholesterol metabolism (abca1) are regulated by Lxr and Srebp TFs in salmon, indicating highly 34 
conserved regulatory mechanism across vertebrates. In addition, srebp1 and srebp2 mRNA respond to 35 
replacement of dietary FO with VO. Thus, Atlantic salmon adjust lipid metabolism in response to 36 
dietary lipid composition through the transcriptional regulation of gene expression. It may be possible 37 
to further increase efficient and effective use of sustainable alternatives to marine products in 38 
aquaculture by considering these important molecular interactions when formulating diets. 39 
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1. Introduction 46 
Lipid content and composition in feeds for farmed fish has experienced a recent and rapid change, 47 
because, in order to sustain growth of the aquaculture industry, ecologically limited marine fish meal 48 
and fish oil (FO) ingredients have been replaced by terrestrial plant-derived meals and oils. Although 49 
replacement of up to 100% dietary FO with vegetable oil (VO) has little effect on growth in Atlantic 50 
salmon (Salmo salar) [1], some studies have shown major effects on the expression and regulation of 51 
genes involved in fatty acid and cholesterol metabolism [2,3]. This impact was consistent with the 52 
major compositional changes caused by feeding VO to fish including decreased levels of dietary 53 
cholesterol and long-chain polyunsaturated fatty acids (LC-PUFA), eicosapentaenoate (EPA; 20:5n-3), 54 
docosahexaenoate (DHA; 22:6n-3) and arachidonate (ARA, 20:4n-6), which are absent in terrestrial 55 
plants [2]. Cholesterol and LC-PUFA are critical functional components of cellular membranes and 56 
are important precursors of bioactive lipids required for homeostasis, cell signaling, immune and 57 
inflammatory responses [4], and the long-term health and welfare effects of reductions in these 58 
essential dietary nutrients in fish, including salmon, are unknown. 59 
Much effort has been directed toward the understanding of effects of dietary imbalances in LC-PUFA 60 
and cholesterol in humans and mammalian models because of the links between dyslipidemia and a 61 
range of highly prevalent cardiovascular, metabolic and inflammatory diseases [5]. These studies have 62 
shown that cholesterol and fatty acids and their metabolic derivatives can exert major effects on 63 
physiology by interactions with a range of transcription factors [6]. Particular attention has focused on 64 
liver X receptor (LXR), peroxisome proliferator-activated receptors (PPAR) and sterol regulatory 65 
element binding proteins (SREBP) and their activities in liver and monocyte cells. LXR has a pivotal 66 
role in the control of intermediary metabolism mediating cross-regulation between fatty acid and 67 
sterol metabolism [7]. LXR activity is activated by binding oxysterol ligands, catabolic products of 68 
cholesterol [8]. In response to cholesterol overloading, and consequent oxysterol production, LXR 69 
modulates intracellular cholesterol levels by transactivating the expression of cholesterol ester transfer 70 
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protein, apolipoproteins, cholesterol 7alpha-hydroxylase (CYP7α1) and the ATP-binding cassette 71 
transporter 1 (ABCA1), which regulate cholesterol efflux from cells [7].  72 
In response to cholesterol depletion, SREBPs, a family of membrane-bound transcription factors, are 73 
activated. SREBP1 plays a crucial role in the regulation of many lipogenic genes and SREBP2 74 
primarily regulates the transcription of cholesterogenic enzymes [9]. Interactions between these 75 
pathways are to some extent mediated through LXR activating SREBP1 transcription, inducing the 76 
expression of enzymes involved in the synthesis of fatty acids, triacylglycerols and phospholipids. In 77 
addition, some important lipid metabolizing genes, such as fatty acid synthase (FAS), are both LXR 78 
and SREBP1 targets [10]. PPARs, encoded by three genes in mammals, are activated by binding fatty 79 
acids or their oxidized derivatives and act to regulate expression of genes of lipid degradation and 80 
biosynthesis. PPARα and PPARβ, regulate the expression of genes encoding mitochondrial and 81 
peroxisomal fatty acid-catabolizing enzymes, whilst PPARγ has a central role in fat storage by 82 
promoting and maintaining the adipocyte phenotype [6]. Thus, LXR, SREBP and PPAR transcription 83 
factors act as lipid sensors that translate changes in cellular sterol and fatty acid content and 84 
composition into metabolic activity. 85 
Compared to mammals, few studies have addressed the existence or roles of these transcriptional 86 
regulators of lipid metabolism in fish. Our contention is that a greater understanding of lipid-mediated 87 
gene regulatory networks in Atlantic salmon will facilitate the efficient, effective and safe use of 88 
sustainable alternatives to marine products in aquaculture feeds. Recently the genes for Atlantic 89 
salmon Lxr, Srebp1 and Srebp2 and Ppars have been characterized [11-13]. In addition, studies on an 90 
Atlantic salmon cell line (SHK-1) have shown that several lipid metabolic genes are transcriptionally 91 
regulated in response to changes in lipid composition of the medium [13]. The primary aim of the 92 
present study was to elucidate Lxr, Srebp and Ppar gene regulatory mechanisms and key lipid 93 
metabolic target genes in Atlantic salmon and to determine the extent to which dietary modulation of 94 
lipid and fatty acid metabolism in salmon reflects or varies from the patterns of gene regulation 95 
described for mammals. 96 
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 97 
2. Materials & Methods 98 
2.1. Cell lines and cell culture 99 
The established Atlantic salmon cell line derived from head kidney (SHK-1) was grown at 22 °C in an 100 
atmosphere of 4 % carbon dioxide in Dulbecco's modified eagle medium (DMEM) containing 3 g L-1 101 
D-glucose and 55 mg L-1 sodium pyruvate, and supplemented with 10% foetal bovine serum (FBS), 102 
50 U mL-1 penicillin, 50  μg  mL-1 streptomycin,  40  μM  2-mercaptoethanol and 4 mM L-glutamine. For 103 
gene promoter transactivation assays, fathead minnow (Pimephales promelas; FHM) epithelial cells 104 
were maintained at 22 °C  in  Leibovitz’s  L-15 with GlutaMAXTM-1 medium containing 900 mg L-1 D+ 105 
galactose and 550 mg L-1 sodium pyruvate and 10% FBS. All media and supplements were obtained 106 
from Life Technologies (Glasgow, UK).  107 
For subculturing, the cell monolayer was washed twice with phosphate buffer saline (PBS) without 108 
CaCl2 or MgCl2 (Invitrogen, UK), cells detached by incubation with 0.05 % trypsin/0.02 % EDTA 109 
and re-suspended in medium. Viable cells were counted after harvesting using a Neubauer 110 
haemocytometer, 0.4 % Trypan blue (Sigma, Dorset, UK) and an inverted microscope (IMT-2, 111 
Olympus).  112 
For transcription factor (TF) ligand treatments, SHK-1 cells were seeded in 6-well clear plates (Nunc, 113 
Denmark) at a density of 4 x 105 cells  per  well  in  a  volume  of  3  ml  Leibovitz’s  L-15 medium. Cells 114 
were approximately 70 % confluent after 48 h growth, when medium was aspirated, cells washed 115 
twice with PBS and fresh medium containing the various treatments as ethanol solutions was added. 116 
Final  concentrations  were  cholesterol  (20  μM),  WY14643  (25  μM),  2-bromopalmitate (25  μM),  or  117 
LXR  agonists  (GW3965  and  T0901317,  10  μM)  or  with  ethanol  carrier  alone  (100% ethanol). After 118 
24 h, the medium was aspirated, the cell monolayer washed twice (PBS) and cells scraped from each 119 
well in 0.5 ml of PBS. Cells were centrifuged for 5 min at 3000 x g, PBS discarded and replaced by 120 
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0.5 ml of TriReagent (Ambion, UK), followed by vigorous mixing to lyse and digest cells.  Cells from 121 
two wells were pooled to produce three replicates per treatment. 122 
2.2. Fish, diets and sampling protocols 123 
Four diets (4 mm pellets) with the same basal protein composition, but coated with four different oils 124 
were formulated at Skretting Technology Centre (Stavanger, Norway) to satisfy the nutritional 125 
requirements of salmonid fish [14]. The oils used were FO (anchovy oil), or 100 % replacement with 126 
rapeseed oil (RO), linseed oil (LO) or soybean oil (SO). Atlantic salmon post-smolts (130 g) were 127 
randomly distributed into 16 tanks at the Skretting Aquaculture Research Centre (Stavanger, Norway). 128 
After a conditioning period of 3 weeks during which the fish received a commercial diet containing 129 
FO, the fish were fed the experimental diets to satiation for a period of 16 weeks. Full descriptions of 130 
the diet compositions and experimental conditions were reported previously [2]. At the end of the trial 131 
fish were anaesthetized with metacain (50 mg/L) and pyloric caeca (intestine), a major organ involved 132 
in uptake and transport of lipids, were dissected from five randomly selected fish from each dietary 133 
treatment. Samples of 0.5 g of caeca were immediately and rapidly disrupted in 5 ml of TriReagent 134 
(Ambion, UK) using an Ultra-Turrax homogenizer (Fisher Scientific, UK), and stored at - 80 ºC prior 135 
to RNA extraction. The dietary trial and all procedures on Atlantic salmon conformed to European 136 
ethical regulations regarding the care and use of farmed animals in research. 137 
2.3. Atlantic salmon LXR activation assay 138 
The ligand binding domain (LBD) (amino acid residues 191-462) [GenBank:FJ470290] of Lxr was 139 
amplified  by  PCR  from  salmon  pyloric  caeca  cDNA  using  primers  (Supplementary  Table  1)  with  5’  140 
restriction sites to allow in-frame subcloning between the BamHI and XbaI sites of the pBIND vector 141 
(Promega, Southampton, UK), which contains the yeast GAL4 DNA-binding domain [8]. The 142 
resulting pBIND-Lxr chimeras were co-transfected with a reporter gene plasmid in which the Firefly 143 
luciferase gene is under the control of a promoter containing UAS (upstream activation sequence), 144 
which is recognized by Gal4. To control differences in transfection efficiency, a constitutively 145 
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expressed control reporter construct encoding for Renilla luciferase was included. Ligand activation 146 
of Lxr was determined by a luciferase-based functional assay using the FHM cell line as described 147 
previously [15]. Twenty-four hours prior to transfection, 2 x 104 cells per well were seeded in a 96-148 
well black-sided, clear-bottom microtitre plate (Corning, NY, USA). Transfection mixtures contained, 149 
per well; 100 ng pBIND-Lxr construct, 60 ng of luc2P/GAL4UAS reporter plasmid (pGL4.31, 150 
Promega), 20 ng of hRluc/CMV internal control reporter plasmid (pGL4.75,  Promega)  and  1.5  μl  of  151 
Polyfect transfection reagent (Qiagen) in 100  μl  of  L-15 medium. Within each experiment, treatments 152 
were performed in triplicate. Experimental controls included treatments in which the pBIND-Lxr 153 
construct was replaced by empty pBIND vectors during transfection, as well as cells transfected with 154 
the appropriate pBIND-Lxr construct and reporters and treated with ethanol carrier only. After 24 h, 155 
transfection mixes were removed and replaced with media containing treatment vehicle (ethanol), 156 
cholesterol, or one of the following LXR agonists: natural oxysterols 20(S)-hydroxycholesterol (20S-157 
OH) and 22(R)-hydroxycholesterol (22R-OH), synthetic agonists T0901317 and GW3965, and the 158 
fungal molecule paxilline (Sigma Aldrich, UK). Compounds of interest were diluted into L-15 from 159 
ethanolic  stock  and  100  μl  of  the  dilution  was  added  per  well  and  incubated  for  24  h.  Cells  were  lysed  160 
by  10  min  incubation  in  75  μl  per  well  of  1x  Passive  Lysis  Buffer  (Promega),  and  Firefly and Renilla 161 
luciferase activities quantified using an assay protocol described previously [15]. Transactivation 162 
activities were obtained using VICTOR X Multilabel plate reader (PerkinElmer, USA) and data were 163 
normalized to the Renilla luciferase activities. Data are presented as means of raw transactivation 164 
activities of three independent assays. The significance of effects of treatments were tested by one-165 
way  analysis  of  variance  (ANOVA),  followed  by  multiple  comparisons  using  Tukey’s  post hoc test at 166 
a significance level of P ≤  0.05  (PASWS  18.0,  SPSS  Inc.,  USA).   167 
2.5. Quantitative RT-PCR (qPCR)  168 
Salmon caecal samples from fish fed different oil sources (n = 5), or SHK-1 cells exposed to Lxr- or 169 
Ppar-ligands (n = 3) were used for relative and absolute qPCR analyses, respectively. For gene 170 
expression analysis, samples were immediately and rapidly disrupted in TriReagent, and stored at - 80 171 
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ºC  prior  RNA  extraction.  Total  RNA  was  extracted  following  the  manufacturer’s  instructions  172 
(Ambion, UK), and the quantity and quality of isolated RNA determined by electrophoresis and 173 
spectrophotometry (Nanodrop 1000, Thermo Scientific, USA). One microgram of total RNA was 174 
reverse transcribed into cDNA using the Verso cDNA synthesis kit (Thermo Scientific, UK) and 175 
primed with random hexamers and oligo(dT) in a 3:1 molar ratio. The resulting cDNA was diluted 20-176 
fold with nuclease-free water. For quantitative qPCR, oligonucleotide primers for target genes and 177 
housekeeping genes (elf-1α and β-actin)  (Supplementary  Table  1)  were  used  at  0.3  μM  with  one-178 
fortieth  of  the  cDNA  synthesis  reaction  (5  μl  of  a  1:20  dilution)  and  10  μl  of  SYBR-green qPCR mix 179 
(ABgene,  UK)  in  a  total  volume  of  20  μl.  Reactions  were  run  in  a  Mastercycler  RealPlex2 (Eppendorf, 180 
UK). Amplifications were carried out including systematic negative controls containing no cDNA 181 
(NTC, no template control) and omitting reverse transcriptase enzyme (-RT) to check for DNA 182 
contamination. Thermal cycle and melting curves were performed as described previously with 183 
specific annealing temperatures for each primer pair shown in Supplementary Table 1 [16]. The qPCR 184 
product sizes were checked by agarose gel electrophoresis and the identity of random samples 185 
confirmed by sequencing. Absolute quantification was achieved by including a parallel set of 186 
reactions containing spectrophotometrically-determined standards consisting of serial dilutions of 187 
known copy numbers of linearised plasmid that contain the predicted amplification product for each 188 
measured gene. Results were expressed as mean normalized ratios (± SE) between the copy number 189 
of target genes and the mean copy number of the reference genes (elf-1α and β-actin). Differences in 190 
the expression of target genes among different treatments were determined by one-way analysis of 191 
variance  (ANOVA),  followed  by  multiple  comparisons  using  Tukey’s  post hoc test (PASWS 18.0, 192 
SPSS Inc., USA). In contrast, the effects of diet on TF expression were analyzed for statistical 193 
significance using the relative expression software tool (REST-MCS, 2009 V2 [http://www.gene-194 
quantification.de/rest-2009.html]), and normalized by two housekeeping genes (elf-1α and β-actin). 195 
Gene expression was presented as the relative expression ratio of each gene in fish fed one of the VOs 196 
or FO. A significance of P ≤  0.05  was  applied  to  all  statistical  tests  performed.   197 
2.6. Expression constructs and cell transfection assays 198 
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Atlantic salmon transcription factors Lxr [GenBank: FJ470290], Pparα [GenBank: AM230809], 199 
Pparβ1a [GenBank: AJ416953], Srebp1 [GenBank: HM561860] and Srebp2 [GenBank: 200 
HM561861NM_004599] had been previously described [12,13]. The entire open reading frame of Lxr 201 
(Lxr ORF, 1-462 amino acids), Pparα (Pparα ORF, 1-464 aa), Pparβ1a (Pparβ ORF, 1-443 aa), and 202 
the soluble N-terminal domains of Srebp1 (nSrebp1, 1-476 aa) and Srebp2 (nSrebp2, 1-460 aa) were 203 
amplified from caecal cDNA samples using the primers detailed in Supplementary Table 1, which 204 
included suitable restriction sites, EcoRI and XhoI, for subsequent insertion into the CMV-based 205 
constitutive expression vector pcDNA3 (Invitrogen, UK). Positive clones were selected by enzymatic 206 
digestion and sequenced (CEQ-8800 Beckman Coulter Inc., USA). The putative promoter regions, 207 
first non-coding exon, first intron and the ATG start codon of Atlantic salmon elovl5a (-3618, 208 
[GenBank:GU238431]), elovl5b (-3141, [GenBank:GU324549]), and fads2d6a (-1791, 209 
[GenBank:AY736067]) were amplified from genomic DNA using high-fidelity PfuTurbo DNA 210 
Polymerase (Statagene, UK) and primers containing restriction sites (Supplementary Table 1). These 211 
fragments were cloned into SacI and NcoI or XhoI sites encompassing the luciferase start codon of a 212 
promoterless reporter plasmid [pGL4.10, luc2] (Promega, USA), which encodes Firefly luciferase. 213 
For luciferase assays, FHM cells were co-transfected, under the conditions described previously, with 214 
the salmon elovl5 or fads2d6a reporter constructs, Lxr, Pparα, Pparβ1a, nSrebp1 or nSrebp2 215 
expression constructs to overexpress the protein product. Briefly, stock FHM cells were seeded in 96-216 
well opaque plates at a density of 2 x 104 per well 24 h prior to transfection. Transfection mixtures 217 
consisted of 50 ng of pGL4.10 reporter construct (empty pGL4.10 vector in controls), 30 ng of 218 
pcDNA3 expression construct (empty pcDNA3 vector in controls), 20 ng of Renilla pGL4.75  and  1  μl  219 
of  Polyfect  transfection  reagent  to  100  μl  of  L-15 medium. Within each transfection experiment, each 220 
treatment was performed in triplicate. After 24 h, the medium was aspirated, monolayer washed twice 221 
with PBS, cells lysed, and Firefly and Renilla luciferase activities quantified as described previously 222 
[15]. Transactivation activities were obtained, data normalized and statistical analyses performed as 223 
described above. 224 
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 225 
3. Results 226 
3.1. Ligand specificity of Atlantic salmon LXR 227 
Prior to testing for Lxr-dependent gene expression the ligand binding specificity of S. salar Lxr was 228 
determined. The salmon Lxr/Gal4 chimera was activated by synthetic Lxr ligands, including 229 
T0901317, GW3965 and paxilline, and also by the physiological oxysterols, 22(R)-OH and 20(S)-OH 230 
(Fig.1). The concentration-response curve for activation of Lxr indicated that T0901317 and GW3965 231 
were the most potent agonists (Fig. 1). T0901317 and GW3965 activated salmon Lxr at micromolar 232 
concentrations with maximal effect observed  at  10  μM.  The  synthetic  agonist  paxilline  exhibited  the  233 
lowest  effect,  whereas  cholesterol  had  no  effect.  No  response  was  detected  at  100  μM  for  most  234 
agonists, perhaps due to toxic effects.  235 
3.2. Gene expression in SHK-1 cells  236 
Salmon SHK-1 cells were incubated with Lxr (T091317 and GW3965) and Ppar (Wy14643 and 2-237 
bromopalmitate) agonists to identify respective target genes. Incubation with synthetic Lxr ligands 238 
caused potent induction of srebp genes, with up to 9-fold increase for srebp1 and 2-fold for srebp2 239 
(Fig. 2). Lxr agonists GW3965 and T091317 increased the expression of fas mRNA 3- and 6-fold, 240 
respectively (Fig. 3). Fatty acyl desaturases, fads2d6a (~3.3-fold), fads2d6b (~2.4-fold) and fads2d5 241 
(4-fold) mRNAs were increased by GW3965. Only fads2d5 expression was affected by T091317 242 
being increased < 2-fold (Fig. 3). The expression of mRNA for abca1 transporter, which regulates 243 
cholesterol efflux, was strongly upregulated by both Lxr agonists, with ~14-fold increases (Fig. 3). In 244 
the presence of Ppar agonists, only srebp2 expression responded, relatively weakly, to 2-245 
bromopalmitate (Fig. 2), which is a dual Pparα and Pparβ agonist. However, Wy1465, a specific 246 
Pparα agonist had no significant effect on srebp2 expression. The expression of acyl-CoA oxidase 247 
(acox), HMG-CoA reductase (hmgCoAR) and fatty acid elongases, elovl4, elovl5a and elovl5b (Fig. 3) 248 
and ppars (Fig. 2) did not change significantly after incubation with Lxr or Ppar ligands.  249 
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3.3. Trans-regulation of genes related to LC-PUFA metabolism by Srebp, Lxr and Ppar 250 
To investigate the regulatory role of Srebp, Lxr and Ppar on the expression of key genes of LC-PUFA 251 
biosynthesis, we established Atlantic salmon promoter luciferase assays in FHM cells. The Srebp 252 
transcriptional regulation of duplicated elovl5a and elovl5b elongases, and fads2d6a desaturase 253 
promoters was assessed by co-transfecting with the active nuclear DNA-binding region of either 254 
Srebp1 or Srebp2. Consistent with previous in vitro observations that fads2d6a contains an SRE 255 
response element in the promoter region [17] the data indicate that both Srebp1 and Srebp2 promote 256 
the expression of fads2d6a. The promoters of both elovl5a and elovl5b duplicated genes were also 257 
highly activated (Fig. 4) and Srebp2 showed higher activity than Srebp1 for elovl5b and fads2d6a, 258 
whereas elovl5a was activated equally by both Srebp mature proteins. Co-transfection of FHM cells 259 
with ligand-activated salmon Ppars did not stimulate expression from elovl5a, elovl5b, or fads2d6a; 260 
promoters, however the fads2d6a promoter was significantly activated by Lxr (Fig. 5).  261 
3.4. Nutritional regulation of the expression of transcription factors 262 
Regulation of TF genes in response to dietary lipid composition was examined in pyloric caeca from 263 
salmon post-smolts fed diets containing either FO rich in EPA, DHA and cholesterol, or VOs rich in 264 
C18 FA, 18:1n-9 (RO), 18:2n-6 (SO), or 18:3n-3 (LO) but lacking LC-PUFA and cholesterol [2]. 265 
Compared to the FO-fed group, there was a significant increase of srebp1 and srebp2 transcripts in the 266 
pyloric caeca of fish fed the RO and LO diets (Fig. 6). The same trend was observed in fish fed the 267 
SO diet suggesting biological significance although not statistically. No differences were found 268 
between the dietary groups with regard to the expression of lxr or ppar α, β or γ. 269 
 270 
4. Discussion 271 
Elucidating the regulation of lipid and fatty acid metabolism in fish at a fundamental level is critical to 272 
understanding the relationships between lipid biosynthesis and metabolism and dietary lipid supply in 273 
fish, and will be crucially important to sustain the growth of aquaculture against a background of 274 
  
12 
static or diminishing supplies of fish oil derived from wild fisheries. To address these relationships we 275 
have undertaken this study to investigate the role of key lipid-regulated TFs on several salmon genes 276 
in an Atlantic salmon cell line, SHK-1, with a focus on genes of the LC-PUFA biosynthetic pathway. 277 
The SHK-1 cell line was initially developed from salmon head kidney tissue and is possibly 278 
leucocyte-derived, showing both macrophage- or dendritic-like phenotypes [18]. However, as a 279 
suitable salmon liver- or intestine-like cell line is lacking, the SHK-1 cell line was recently 280 
successfully utilized as a model for studying salmon lipid metabolism [13] on the basis that the 281 
critical transcriptional regulators of macrophage lipid homeostasis were the same as those in liver and 282 
they regulated similar target genes [19,20]. Thus, the response of this cell line to supplementation or 283 
depletion of cholesterol or fatty acids suggested the involvement of Srebp and Lxr in regulating 284 
several critical lipid biosynthetic genes [13]. To extend these studies and investigate the roles of 285 
individual TFs and their target genes more specifically we first characterized the ligand-activation 286 
dependency of Lxr and developed promoter/reporter gene constructs to investigate the role of Srebp, 287 
Lxr and Ppar in Atlantic salmon. 288 
4.1. Lxr ligand activation 289 
A single Lxr subtype has been identified in various fish species (compared to two in mammals), and 290 
all show a highly conserved structure across teleost fish, amphibians, birds and mammals [8]. 291 
Although a salmon lxr cDNA had been characterized the response of the corresponding receptor to 292 
activating ligands had not been tested [12]. Accordingly, concentration-response curves for Lxr 293 
ligands indicated that natural oxysterols including 20S-OH and 22R-OH (but not cholesterol) and the 294 
fungal metabolite paxilline were activators of Atlantic salmon Lxr. As with other vertebrate LXRs [8], 295 
the synthetic agonists T0901317 and GW3965 were strong activators of Atlantic salmon Lxr. Thus the 296 
synthetic agonists T0901317 and GW3965 were considered suitable tools for cellular assays of Lxr 297 
function. 298 
4.2. Transcriptional regulation of genes of the lipid metabolism 299 
  
13 
The genetic control of lipid metabolism involves a complex interplay of transcription factors and 300 
regulatory loops acting on many genes of lipid metabolism and transport. For example, in mammals, 301 
LXR can mediate the regulation of lipogenesis through the direct activation of genes involved in lipid 302 
biosynthesis, or in a SREBP1c-dependent manner [10,21,22]. In mammals, two SREBP1 isoforms, 303 
SREBP1a and SREBP1c, are encoded by a single gene through the use of alternative start 304 
transcription sites, while a separate gene encodes Srebp2 [23]. Given this complexity, elucidated from 305 
studies in human and mammalian models, the present study aimed to determine if similar regulatory 306 
systems exist in fish due to the increasing importance of understanding basic lipid metabolic 307 
processes in modern aquaculture. In agreement with recent studies performed in rainbow trout 308 
(Oncorhynchus mykiss) [24,25], treatment of Atlantic salmon SHK-1 cells with Lxr agonists resulted 309 
in the upregulation of mRNAs for several important lipid metabolic genes, including fas involved in 310 
de novo biosynthesis of fatty acids and abca1, which controls the reverse cholesterol efflux (See 311 
diagram in Fig. 7). Ligand-activated Lxr also induced the expression of both srebp1 and srebp2 in 312 
SHK-1 cells. Similarly, SREBP1c and also FAS and ABCA1 are established direct LXR targets in 313 
various human and rodent systems [10,21,26]. However, the LXR-mediated induction of Srebp2 is not 314 
observed in mammals [22], and may be specific to Atlantic salmon.  According to our results, several 315 
groups have reported LXR autoregulatory behavior in mammals through binding to LXRE (LXR 316 
response element) present in LXRα promoter [26]. 317 
Although vertebrates have the capability for endogenous synthesis of monounsaturated fatty acids 318 
from the saturated fatty acid products of FAS through the action of stearoyl CoA desaturase (SCD or 319 
'9 desaturase), they are incapable of creating LC-PUFA de novo. Vertebrates thus require either 320 
dietary LC-PUFA directly or, depending upon species, they can produce the physiologically important 321 
ARA, EPA and DHA by desaturation and elongation of dietary shorter chain PUFA, linoleic (18:2n-322 
6) and α-linolenic (18:3n-3) acids, through the action of Fads1 and 2 and Elovl5 [27]. Intense interest 323 
has been paid to vertebrate LC-PUFA enzymes given their hormonal, ontogenetic and/or nutritional 324 
regulation in vertebrates [28,29]. Salmon Elovl5 enzymes are encoded by two very similar duplicated 325 
genes [3]. Neither mRNA was affected by Lxr agonist in SHK-1 cells, despite the elovl5 gene 326 
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promoters being activated by co-transfection with nSrebps, which indicates that, although Srebps 327 
were induced in the cell line, under the experimental condition used they were not processed to 328 
transcriptionally active forms. In mammals, Elovl5 is also not an LXR target, but is secondarily 329 
activated through LXR effects on Srebp1c [30]. Salmon fads2 was significantly increased by Lxr 330 
agonist in vitro, and strongly activated by nSrebps indicating that this gene is a direct target of both 331 
transcription factors. In mammals, LXR agonist increased Fads1 and Fads2 expression although the 332 
results were attributed to a secondary LXR-dependent induction of SREBP1c [31]. The promoter 333 
element of the Fads2 gene conferring Srebp1 response is highly conserved in several vertebrates 334 
including Atlantic salmon, with a potential SRE site and a NF-Y cofactor site [17].  335 
Notably, Atlantic salmon elovl5 duplicates exhibit differential tissue expression patterns and respond 336 
differently to dietary nutrients [3,32]. Accordingly, our results show that elovl5a is equally regulated 337 
by both Srebp1 and Srebp2, whereas elovl5b regulation by Srebp2 is 2-fold greater than that exhibited 338 
in response to Srebp1, possibly as result of sequence divergence in the promoter regions of these 339 
genes.  340 
PPARs are also central to the transcriptional control of lipid metabolism and several interactions with 341 
LXRs and SREBPs have been proposed [33,34]. Mice knockout assays and subsequent in silico 342 
analysis confirmed that PPARα induces Srebp1 and Srebp2 expression through the interaction with 343 
PPRE (PPAR response element) in the mammalian Srebp2 promoter [34]. In SHK-1 cells, few effects 344 
were observed upon treatment with WY14643, a Pparα specific ligand, or 2-bromopalmitate, a non-345 
metabolizable fatty acid activator of teleost Pparα and Pparβ [15]. However, bromopalmitate induced 346 
the expression of srebp2, whereas WY14643 had no effect. This suggests a Pparβ-mediated effect, 347 
although it is also possible that the lack of response to the Pparα-specific WY14643 is due to a limited 348 
ppar subtype expression profile in SHK-1 cells. 349 
4.3. Dietary regulation of lipid transcription factors 350 
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The in vivo significance of the results from the SHK-1 cell line and promoter assays was previously 351 
shown by the observation that hepatic srebp2 mRNA levels and LC-PUFA biosynthetic gene 352 
expression and biosynthesis increased in salmon fed diets containing high levels of VO [2]. In this 353 
study, similar results for the expression of LC-PUFA biosynthetic genes were observed in the 354 
intestine (pyloric caeca) of salmon fed VO [3]. The pyloric caeca of salmon constitutes the major 355 
tissue in terms of nutrient uptake, and lipid digestion and transport [35], and is also the tissue that 356 
exhibited the highest level of expression of srebps and lxr mRNAs in Atlantic salmon [13]. Therefore, 357 
if the LC-PUFA biosynthetic genes, elovl5 and fads2, are driven by Srebps in vivo, then the same 358 
increase in Srebps should be observed in intestine from VO-fed fish. As the present study has shown, 359 
this was indeed the case. Our results indicated that, among the transcription factors studied, only 360 
srebp1 and srebp2 expression was increased significantly in the pyloric caeca of Atlantic salmon fed 361 
rapeseed oil (RO) and linseed oil (LO) compared to the expression in fish fed FO. Plant-derived 362 
products constitute the perfect activation ground for SREBPs. In the absence of sterols, the TF amino-363 
terminus is proteolytically released from the endoplasmic reticulum membrane and transported into 364 
the nucleus where it binds SRE (serum response element) of specific sets of target genes [36]. In 365 
mammals, SREBP1 recognizes SRE sites in the promoters of Srepb1 and Srebp2 [37], thus it is likely 366 
that salmon Srebp1 activated in low sterol conditions, induced by the inclusion of VO, promoted its 367 
own expression and that of srebp2 in a positive-feedback mechanism. Despite TF responses to dietary 368 
lipid variations in fish have been reported at specific developmental stages [12], no effects of VO 369 
inclusion were observed in the expression of lxr or ppar in this study.  370 
5. Conclusions 371 
The results of the present study showed that the fatty acyl elongases and desaturases responsible for 372 
endogenous production of LC-PUFA from PUFA in Atlantic salmon were primarily regulated by 373 
Srebps, and that Lxr may also be involved in regulating desaturases, but not elongases, whereas there 374 
was no evidence for a direct role of Ppars, at least in the salmon cell line tested. ABCA1, a gene 375 
central to the process of reverse cholesterol transport, and which is a direct LXR target in mammals, 376 
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was also a target of Lxr in salmon. Furthermore fas and both srebp genes, responsible for the major 377 
steps of lipogenesis, are direct Lxr targets in salmon as they are in mammals. Thus, overall, the 378 
transcriptional regulatory systems that drive cholesterol transport from the cellular space to 379 
lipoprotein, initiate lipogenesis, and regulate LC-PUFA biosynthesis in mammals are largely 380 
conserved in Atlantic salmon. This knowledge will be key to deriving a conceptual framework for 381 
future experiments designed to answer more applied questions related to lipid metabolism and 382 
nutrition with regard to the development and optimization of more sustainable aquaculture feeds. 383 
Importantly the present results also showed that these lipid regulatory factors and the genes that they 384 
target are ancient, likely to be have arisen early in vertebrate evolution. Thus, further basic studies of 385 
evolutionarily conserved pathways of lipid metabolic control across vertebrates might also elucidate, 386 
through definition of fundamental regulatory mechanisms, medically relevant aspects of human lipid 387 
nutrition and metabolism. 388 
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Figure captions 509 
Figure 1. Activation of Atlantic salmon LXR. 510 
Concentration-response curve for activation of Atlantic salmon LXR ligand-binding domain by 511 
T091317, GW3965, paxilline, cholesterol and oxysterols (20S-OH and 22R-OH). FHM cells were 512 
transfected with Gal4-LXR constructs, firefly luciferase reported plasmid pGL4.31 and an internal 513 
Renilla luciferase reporter to correct for transfection efficiencies. The ordinate represents activation of 514 
LXR as arbitrary units of firefly luciferase normalized to Renilla luciferase. Data points represent the 515 
mean of three independent experiments (n = 9). 516 
Figure 2. Effects LXR and PPAR agonists on transcription factor gene expression in Atlantic 517 
salmon SHK-1 cells. 518 
Expression of lxr, srebp1, srebp2, pparα, pparβ and pparγ in SHK-1 cells exposed to 20  μM  519 
cholesterol  (Chol),  10  μM  of  LXR  agonists  T0901317  (T0)  or  GW3965  (GW),  25  μM  of  PPAR  520 
agonists 2-bromopalmitate (2-BP) or WY14643 (WY), or carrier alone (EtOH). Gene expression is 521 
expressed as mean normalized ratios (n = 3, ± SE) between the copy numbers of target genes and the 522 
mean copy number of the reference genes (elf-1α and β-actin). Bars bearing different letters are 523 
significantly  different  (ANOVA;;  Tukey’s  test;;  P < 0.05). 524 
Figure 3. Effects LXR and PPAR agonists on lipid metabolic gene expression in Atlantic salmon 525 
SHK-1 cells. 526 
Expression of Atlantic salmon lipid metabolic genes in SHK-1  cells  exposed  to  20  μM  cholesterol  527 
(Chol),  10  μM  of  LXR  agonists  T0901317  (T0)  or  GW3965  (GW),  25  μM  of  PPAR  agonists  2-528 
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bromopalmitate (2-BP) or WY14643 (WY), or carrier alone (EtOH). Gene expression was expressed 529 
as mean normalized ratios (n = 3, ± SE) between the copy numbers of target genes and the mean copy 530 
number of the reference genes (elf-1α and β-actin). Bars bearing different letters are significantly 531 
different  (ANOVA;;  Tukey’s  test;;  P < 0.05).  532 
Figure 4. Effects of SREBPs on LC-PUFA gene promoters. 533 
Co-transfection in FHM cells with Srebp1, or Srebp2 expression constructs (empty pcDNA3 534 
expression vector as control), and reporter pGL4.10 [luc2] directed by the promoters of salmon 535 
elovl5a (- 3618 nt), elovl5b (- 3141 nt), or fads2d6a (- 1791 nt). Error bars indicate SE between data 536 
points (n = 3) of independent luciferase assays. * Significant differences between treatments are 537 
indicated  (ANOVA;;  Tukey’s  test;;  P < 0.05). 538 
Figure 5. Effects of LXR and PPARs on LC-PUFA gene promoters. 539 
Co-transfection in FHM cells with Pparα or Pparβ expression constructs (empty pcDNA3 expression 540 
vector as control), and reporter pGL4.10 [luc2] directed by the promoters of salmon elovl5a (- 3618 541 
nt), elovl5b (- 3141 nt), or fads2d6a (- 1791 nt). After transfection, FHM cells were incubated with 542 
Ppar agonists WY14643 (25 µM) or 2-bromopalmitate (2-BP, 25 µM), Lxr synthetic agonist GW3965 543 
(10 µM), or ethanol carrier (EtOH). Error bars indicate SE between data points (n = 3) of independent 544 
luciferase assays.  *  Significant  differences  between  treatments  are  indicated  (ANOVA;;  Tukey’s  test;;  545 
P < 0.05). 546 
Figure 6. Nutritional regulation of transcription factor mRNA in Atlantic salmon intestine. 547 
lxr, srebp1, srebp2, pparα, pparβ and pparγ mRNA expression in Atlantic salmon fed diets containing 548 
fish oil (FO), rapeseed oil (RO), soybean oil (SO), or linseed oil (LO) in the pyloric caeca determined 549 
by RT-qPCR. The results shown are means (n = 5) ± SE of normalized  expression  (β-actin and 550 
elongation factor-1alpha reference genes) in relative units (RU). Bars bearing different letters 551 
represent significant differences between dietary treatments for the respective transcripts (REST-MCS 552 
2009 V2; P < 0.05). 553 
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Figure 7. Diagram indicating LXR and SREBP target genes.  554 
A) SHK-1 cells incubated with synthetic Lxr agonists (T0901317 and GW3965) showed that Lxr 555 
regulates multiple genes of the lipid biosynthetic pathway, mediating cross-regulation between 556 
cholesterol and fatty acid biosynthesis. Transcriptional expression of srebp was induced by Lxr 557 
agonist in vitro and dietary lipids (vegetable oils) in salmon intestine. B) Co-transfection assays in 558 
FHM cells indicated that Srebp1 and Srebp2 promote the transcription of elovl5 and fads2, genes of 559 
the LC-PUFA biosynthesis; ER, endoplasmic reticulum; n, amino-terminus.  560 
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